The small study in patients with a rare disorder that causes liver and lung damage showed the potential for precisely targeted infusions. Genetic Engineering, Alpha-1 Antitrypsin Deficiency, Rare and Orphan Diseases, Research, Lungs, Liver, Cirrhosis, Genetics and Heredity, Crispr (DNA), Beam Therapeutics Inc NYT > Health
The small study in patients with a rare disorder that causes liver and lung damage showed the potential for precisely targeted infusions.
